NeoGenomics, Inc. Current Income Tax Expense (Benefit)
NeoGenomics, Inc. (NEO) reported Current Income Tax Expense (Benefit) of $866.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-17
- NeoGenomics, Inc. current income tax expense (benefit) for fiscal 2025 was $866.00K, a 38.56% increase from fiscal 2024.
- NeoGenomics, Inc. current income tax expense (benefit) for fiscal 2024 was $625.00K, a 59.85% increase from fiscal 2023.
- NeoGenomics, Inc. current income tax expense (benefit) for fiscal 2023 was $391.00K, a 157.24% increase from fiscal 2022.
- NeoGenomics, Inc. current income tax expense (benefit) for fiscal 2022 was $152.00K, a 85.37% increase from fiscal 2021.
| Period end | Current Income Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $866.00K 10-K · filed 2026-02-17 |
| 2024-12-31 | $625.00K 10-K · filed 2026-02-17 |
| 2023-12-31 | $391.00K 10-K · filed 2026-02-17 |
| 2022-12-31 | $152.00K 10-K · filed 2025-02-18 |
| 2021-12-31 | $82.00K 10-K · filed 2024-02-20 |
| 2020-12-31 | -$161.00K 10-K · filed 2023-02-24 |
| 2019-12-31 | -$13.00K 10-K · filed 2022-02-25 |
| 2018-12-31 | -$322.00K 10-K · filed 2021-02-25 |
| 2017-12-31 | -$77.00K 10-K · filed 2020-02-28 |
| 2016-12-31 | $31.00K 10-K · filed 2019-02-26 |
| 2015-12-31 | $157.00K 10-K · filed 2018-03-13 |
| 2014-12-31 | $157.00K 10-K · filed 2017-03-14 |
| 2013-12-31 | $152.00K 10-K · filed 2016-04-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |